The Human Epilepsy Project (HEP)

Location:

Rochester, Minn.

Trial status:

Open for Enrollment

Why is this study being done?

The Human Epilepsy Project (HEP) is a prospective, observational study; this means that participants will not be given any additional treatment as part of the study beyond what is clinically indicated.The Human Epilepsy Project (HEP) hopes to identify factors that will predict how patients with focal epilepsy will do on a given seizure medication, whether they will have side effects, and whether they will have more seizures.

Who is eligible to participate?

Participants must be between 12 and 60 years old, and also have been diagnosed with focal seizures between the ages of 12 and 60 years old. Seizures must be focal and participants may have only been taking anti-epileptic medication for less than 4 months.

What is involved?

Involvement in HEP requires daily completion of a seizure diary (using an iPOD Touch provided to participants), completion of questionnaires, a study MRI and/or EEG (paid for by the study), and annual blood collections.

How long is the study?

Participants will be in the HEP study for 3-5 years. Typically visits are only one time per year, and usually can be done at the time of a scheduled clinic visit.

IRB Number:

12-010106